AR	adequate response to therapy on early response assessment
C4BPA	C4b-binding protein α chain
CLU	clusterin
COPDAC-28	consolidation chemotherapy cycle: cyclophosphamide, vincristine, prednisone and dacarbazine, given every 28 days
COPP	chemotherapy cycle: cyclophosphamide, vincristine, prednisone and procarbazine
DECOPDAC-21	consolidation chemotherapy cycle: cyclophosphamide, vincristine, prednisone, etoposide, doxorubicin and dacarbazine, given every 21 days
FDR	false discovery rate
ELISA	enzyme-linked immunosorbent assays
ERA	early response assessment
GO	Gene Ontology
HL	Hodgkin lymphoma
IR	inadequate response to therapy on early response assessment
LC-MS/MS	liquid chromatography coupled to tandem mass spectrometry
LFQ	label-free quantification
NR	non-relapsed
OEPA	induction chemotherapy cycle: vincristine, etoposide, prednisone and doxorubicin, given every 28 days
R	relapsed
SERPINA1	α-1-antitrypsin